Skip to main content

Gaza pharmacists survive by 'lending' diplomas to investors

The dire economic situation in Gaza has driven pharmacology graduates to charge investors a fee for the use of their degrees to obtain pharmacy licenses.
BEIT HANOUN, GAZA STRIP - SEPTEMBER 08: A medical worker shows capsules as he works at the Middle East Company for Pharmaceutical Industries September 08, 2008 in Bait Hanoun, Gaza Strip. Constructed in 1999, the factory is said to be the only producer of pharmaceuticals in Gaza Strip. It's currently using only one production line due to the lack of raw materials because of a trade embargo with Israel.  (Photo by Abid Katib/Getty Images)
Read in 

In the Gaza Strip's struggling economy, “lending” one’s degree or diploma to obtain income has become an increasingly popular practice in the field of pharmacology. With a dearth of job opportunities due to the political situation and the Israeli blockade, and unable to afford opening their own pharmacy, many pharmacology graduates have been trading on their degrees to help private investors open pharmacies and in some cases to work in them.

Khalil Hachem holds a bachelor’s in pharmacology and was completely unaware of the job market in his field at graduation. He explained to Al-Monitor, “If I had the chance again, I would have chosen a different major, because a pharmacy degree in the Gaza Strip is nothing more than a government license to trade in drugs. The pharmaceutical market is limited to selling or promoting pharmaceuticals, because the government positions in the Palestinian Authority-affiliated institutions have been suspended in Gaza in light of the political differences between Hamas and Fatah, not to mention the fact that several pharmaceutical factories are out of business because of the Israeli blockade on Gaza. The only solution is for pharmacists to own their own pharmacy, which is a venture costing between $20,000 and $40,000. As no new graduates can afford such amounts, the majority of them end up lending their diplomas to investors.”

Access the Middle East news and analysis you can trust

Join our community of Middle East readers to experience all of Al-Monitor, including 24/7 news, analyses, memos, reports and newsletters.

Subscribe

Only $100 per year.